Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab

• Metastatic SCC arising from the ovary is rare, and the optimal treatment is unknown. • Pembrolizumab successfully treated a patient with metastatic SCC. • Patients on pembrolizumab should be monitored for immune-related adverse events.

Guardat en:
Dades bibliogràfiques
Publicat a:Gynecol Oncol Rep
Autors principals: Wu, Meng, Bennett, Jennifer A., Reid, Pankti, Fleming, Gini F., Kurnit, Katherine C.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2021
Matèries:
Case Reports and Case Series
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8326349/
https://ncbi.nlm.nih.gov/pubmed/34368414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2021.100837
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars